CD4 and COVID-19: GZMA is a marker gene for the CD4+ effector memory cells, and studies have shown that GZMA is expressed at higher levels in mild and moderate COVID-19 patients than in severe patients and healthy controls, and that high expressions of GZMA are characteristic of an effective antiviral immune response in patients with a moderate COVID-19 infection [53,54].